• About us
  • Privacy Policy
  • Terms & Conditions
Investment Innovate
Advertisement
  • World News
  • Politics
  • Business
  • Investing
No Result
View All Result
  • World News
  • Politics
  • Business
  • Investing
No Result
View All Result
Investment Innovate
No Result
View All Result
Home Investing

Sona Nanotech: Leveraging Nanotechnology in Colorectal Cancer Therapy

October 19, 2023
in Investing
0
Sona Nanotech: Leveraging Nanotechnology in Colorectal Cancer Therapy
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Sona Nanotech (CSE:SONA, OTCQB:SNANF) advances nanotechnology medicine through its proprietary gold nanorods that promise to change the face of cancer therapy. Sona Nanotech’s platform technology leverages uniquely biocompatible gold nanorods (GNRs). Biocompatibility is key to the application of nanotechnology in medicine.

For the past several years, Sona has been working hard to develop and operationalize its biocompatible nanoparticle technology for use in targeted cancer therapy. The company is also developing a targeted cancer therapy, leveraging its proprietary Targeted Hyperthermia Therapy (THT) to directly treat cancer cells.

Sona’s GNRs are rod-shaped nanoparticles made of gold and measuring from 10 to 100 nanometers in length. Produced by chemical synthesis, they directly address many of the current limitations of medical nanoparticle technologies. In addition to making them well-suited for cancer treatment, this also unlocks their potential for use in in-vivo medical applications.

Company Highlights

Canadian nanotechnology company, Sona Nanotech has developed an incredibly promising new technology that leverages uniquely biocompatible gold nanorods.The company also plays a key role in the advancement of photothermal medical therapies, particularly enabled by the company’s acquisition of Siva Therapeutics.This acquisition has allowed Sona to advance the development of Targeted Hypothermia Therapy, addressing many of the risks with current cancer treatments — particularly the damage they can cause to other tissues.THT has already proven effective in reducing tumors in small animal studies. Sona’s initial target for the technology will be colorectal cancer.Rapid diagnostic tests represent the company’s other strategic area of focus, including bovine tuberculosis detection and concussion screening.Future applications for Sona’s technology could include:Targeted drug deliveryPhotothermal cosmetic therapyCell imagingAdditional proprietary testing solutions supported by third-party test development services.The company’s leadership and board of directors comprise experienced professionals from across the healthcare and biotechnology sectors.Sona has a clear roadmap to commercialization of its treatment methodology, starting with a near-term catalyst in large animal studies before moving to a human pilot. It also expects a De Novo pathway for medical devices.

This Sona Nanotech is part of a paid investor education campaign.*

Click here to connect with Sona Nanotech (CSE:SONA) to receive an Investor Presentation

This post appeared first on investingnews.com

Previous Post

Investors’ Guide to AI-based Cybersecurity

Next Post

Appia Rare Earths & Uranium

Next Post
Appia Rare Earths & Uranium

Appia Rare Earths & Uranium

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent News

    Three former bosses of UK nurse Lucy Letby, convicted of killing babies, arrested on suspicion of manslaughter

    Three former bosses of UK nurse Lucy Letby, convicted of killing babies, arrested on suspicion of manslaughter

    July 2, 2025
    Israel at a crossroads as Netanyahu prepares to meet Trump

    Israel at a crossroads as Netanyahu prepares to meet Trump

    July 2, 2025
    Endangered turtles share this Mexican beach with SpaceX rocket debris. The company says there’s no risk of harm

    Endangered turtles share this Mexican beach with SpaceX rocket debris. The company says there’s no risk of harm

    July 2, 2025
    K-pop superstars BTS announce end of hiatus with a new album and world tour in 2026

    K-pop superstars BTS announce end of hiatus with a new album and world tour in 2026

    July 2, 2025
    • About us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 investmentinnovate.com | All Rights Reserved

    No Result
    View All Result
    • World News
    • Politics
    • Business
    • Investing

    Copyright © 2025 investmentinnovate.com | All Rights Reserved